Improper Vial Handling: Leaving vials uncapped, touching the rubber stopper with non-sterile objects, or failing to disinfect the stopper before withdrawal
PMID 3374544
Commonly referenced guidance includes: Initial replacement Maintenance For maintenance, the BNF lists adult prophylaxis/maintenance dosing such as 1 mg intramuscularly every 23 months in appropriate cases
4 patients (0.2 cases per 100 patient-years) receiving placebo
These elements can also lower cholesterol levels and reduce high levels of homocysteine, which are associated with increased risk of stroke, heart attack, or dementia
Your provider will personalize the plan based on your goals (skin support vs recovery vs both), prior peptide experience, and tolerance, and may recommend check-ins during the cycle to adjust timing or approach if you notice side effects or plateaued progress